AEMD - oopsy:
On November 26, 2014, Aethlon Medical, Inc. (the “Registrant”) entered into a Securities Purchase Agreement to sell up to $3,300,000 of units, comprised of common stock and warrants ( the “Units”), to one institutional investor (the “Purchaser”) at a price of $0.30 per Unit (the “Agreement”). Each Unit consists of one share of common stock, $0.001 par value per share, and 1.2 five-year warrants (the “Warrants”), each to purchase one share of common stock at an exercise price of $0.30 per share (the “Financing”). Accordingly, up to 11,000,000 shares of common stock and warrants to purchase 13,200,000 shares of common stock may be issued pursuant to the Agreement.
This Financing is expected to close no later than December 2, 2014, subject to customary closing conditions. Roth Capital Partners served as sole placement agent for the Financing and will receive 550,000 Warrants for its services upon the close of the Financing
